Knurr v. Orbital ATK Inc.

276 F. Supp. 3d 527
CourtDistrict Court, E.D. Virginia
DecidedSeptember 26, 2017
DocketCase No. 1:16-cv-1031
StatusPublished
Cited by7 cases

This text of 276 F. Supp. 3d 527 (Knurr v. Orbital ATK Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Knurr v. Orbital ATK Inc., 276 F. Supp. 3d 527 (E.D. Va. 2017).

Opinion

MEMORANDUM OPINION II

T. S. Ellis, III, United States District Judge

Plaintiffs in this federal securities class action allege claims under (i) § 10(b) and Rule 10b—5; (ii) § 14(a) and Rule 14a-9; and (iii) § 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”). Defendants seek threshold dismissal of claims under all three provisions, and this memorandum opinion addresses the questions presented under § 14(a) and the related § 20(a) claims. Specifically, those questions are as follows:

(1)whether the proxy statements alleged to violate § 14(a) of the Exchange Act are (i) statements of fact; or (ii) merely expressions of opinion; and, if those misrepresentations are expressions of opinion, whether the Complaint1 alleges facts that warrant an inference that the .defendants did not actually hold those opinions;
(2) whether under § 14(a) of the Exchange Act plaintiffs must allege and prove facts showing that the defendants’ proxy statement' misrepresentations (i) were made with fraudulent intent or reckless disregard of the truth; or (ii) whether it is sufficient that the Complaint alleges facts that warrant an inference that the-'misstatements were made negligently;
(3) whether under § 14(a) of the Exchange Act, the Complaint alleges a claim against an authorized agent of the corporate defendant and thus adequately states a claim against the corporate defendant; and
(4) whether under § 20(a) of the Exchange Act, the Complaint alleges that the defendants had control over any person liable under § 14(a) of the Exchange Act.

’ These questions have been fully briefed and- argued and are now- ripe for resolution.

I.

Before reciting the pertinent facts, it is important to identify the proper source of those facts. First, as the parties agree and as settled precedent requires, the facts recited here are taken chiefly from the Complaint’s factual allegations, which must be accepted as true at this stage. Cozzarelli v. Inspire Pharm. Inc., 549 F.3d 618, 625 (4th Cir. 2008) (noting that at the motion to dismiss stage, “we must accept plaintiffs’ factual allegations as true”). Defendants have also sought to have additional facts considered by attaching various exhibits to the motion to dismiss.2 Only certain of these documents are appropriately considered at this stage.

Settled circuit authority permits courts to consider external documents in a motion to dismiss when they “are integral to and explicitly relied on in the complaint, and when the plaintiffs do not challenge the document’s authenticity.” Zak v. Chelsea Therapeutics Int’l, Ltd., 780 F.3d 597, 606-07 (4th Cir. 2015) (quotation marks and brackets omitted). The SEC filings attached to defendants’ dismissal motion, the transcripts of the August 10, 2016, November 8, 2016, and March 8, 2017 Orbital ATK conference calls, and the Wells Fargo and Barclays analyst reports are integral to or explicitly referenced in the Complaint, and plaintiffs do not challfenge their authenticity. Accordingly, these documents are appropriately considered at this stage. Similarly, because the Fourth Circuit permits courts to take “judicial notice of published stock prices without converting a motion to dismiss into a motion for summary judgment,” it is, also appropriate to consider the chart summarizing Orbital ATK’s historical stock prices. Greenhouse v. MCG Capital Corp., 392 F.3d 650, 655 (4th Cir. 2004). By contrast, Alliant’s August 1, 2013 conference call is not referenced in the Complaint, nor does the Complaint cite the KeyBank analyst report, so it is inappropriate to consider these documents at the motion to dismiss stage.

II.

The corporate defendant, Orbital ATK, is an aerospace and defense company formed from the 2015 merger of Alliant Techsystems, Inc. (“Alliant”) and Orbital Sciences Corporation (“Orbital Sciences”). With respect to § 14(a), the Complaint also names the following three individual defendants;

(1) Defendant David W. Thompson, who served as Chairman of the Orbital Sciences Board, CEO, and President of Orbital Sciences prior to the merger;
(2) Defendant Garrett E. Pierce, who whs Vice Chairman of the Orbital Sciences Board and CFO of Orbital Sciences prior to the merger; and
(3) Defendant Mark W. DeYoung, who was CEO and President of Alliant prior to the merger.

Prior to their merger, Orbital Sciences and Alliant were both publicly traded aerospace and defense companies that sold products such as rockets and satellites to NASA and the United States military. Of particular importance to this case, Alliant entered into a major ammunition supply contract (“Lake City Contract”) with the United States Army in 2000. Alliant manufactured billions of rounds of small caliber ammunition under this contract at the Lake City Plant in Independence, Missouri which accounted for 13% of Alliant’s total revenues in fiscal year 2010. In fiscal year 2010, Affiant received a four-year renewal on the Lake City Contract. In August 2012, Affiant submitted a bid to the Army to retain the Lake City Contract beyond 2013. The Complaint alleges that Affiant was under pressure to retain the Lake City Contract because Affiant had recently lost a bid to renew another major multi-year ammunition Army contract to Affi-ant’s competitor, BAE Systems PLC. Accordingly, the Complaint alleges that Affi-ant and DeYoung “aggressively bid” on the Lake Cit^ Contract renewal with a “low-ball bid.” (Compl. ¶¶ 47, 38). Affiant and DeYoung’s plan wprked, as Affiant won the renewal of the Lake City Contract on September 28, 2012 for a seven-year term with a three-year extension option and production to begin on October 1, 2013,.

Shortly after production began on the Lake City Contract, Orbital Sciences.and Affiant announced they planned to merge to form Orbital ATK.. As a result .of the merger, Orbital Sciences shareholders would receive .449 shares of Affiant stock for each share they held of Orbital Sciences stock, and Affiant would change its name to Orbital ATK.

On December 17, 2014, Affiant and Orbital Sciences filed a joint proxy statement (“Joint Proxy Statement”) with the SEC concerning the proposed merger. The Joint Proxy Statement contained a letter signed by DeYoung to Affiant shareholders, who had to approve the issuance of Affiant common stock to Orbital Sciences shareholders, and a second letter signed by Thompson to Orbital Sciences shareholders, who had, to approve the merger agreement. Each company held a special shareholders meeting in January 2015, and in February, the shareholders of each company voted to approve the merger,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re: Willis Towers Watson
Fourth Circuit, 2019
Hirtenstein v. Cempra, Inc.
348 F. Supp. 3d 530 (M.D. North Carolina, 2018)
Knurr v. Orbital Atk Inc.
294 F. Supp. 3d 498 (E.D. Virginia, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
276 F. Supp. 3d 527, Counsel Stack Legal Research, https://law.counselstack.com/opinion/knurr-v-orbital-atk-inc-vaed-2017.